Pharmaceutical Technology Editors

Cambrex has completed the expansion of its solid form screening and crystallization process development facility in Edinburgh, Scotland.

Oxular has been granted rare pediatric disease and orphan drug designations by the US FDA for its proprietary drug, OXU-003.

The UK's MHRA has joined the Australia-Canada-Singapore-Switzerland (ACSS) Consortium of regulators.

Recent data, from BIA and Clarivate, has revealed that investment in UK biotech continues to be strong.

Roche will use Dyno’s CapsidMap platform to develop next-generation adeno-associated virus vectors for gene therapies for central nervous system diseases and liver-directed therapies.

The winners were announced during day seven of CPhI Festival of Pharma.

The company will supply its LIMS to the Walter Reed Army Institute of Research (WRAIR) to support vaccine production programs for COVID-19 at WRAIR’s pilot bioproduction facility.

Virtual Touring allows companies to inspect and visit vendor and contract partner sites remotely during the COVID-19 pandemic.

The unexplained illness in a study participant is being reviewed and evaluated by an independent data safety monitoring board and internal clinical and safety physicians.

The companies are entering into an agreement for the late-stage development and large-scale manufacturing of AZD7442, AstraZeneca’s investigational product for treatment and prevention of COVID-19.

The expansion has doubled Cambrex’s footprint to 15,000 ft2, including an added 3500 ft2 of laboratory space.

Rentschler will handle the downstream processing to provide highly purified drug substance at its headquarters in Laupheim, Germany.

The partnership aims to provide a platform of hiPSC-based assays, drug discovery technologies, high-throughput screening, and high-content screening.

Under the contract, Pharm-Olam will offer routine and response clinical services for the development of medical countermeasures.

FDA approved the first commercial drug manufactured via Aji Bio-Pharma's proprietary production process.

With a recent expansion, Almac will now have the ability to include enhanced analytical method development and bioanalytical testing.

The merged company can offer enhanced statistical and data analytics services.

Natoli installed a NP-RD30 rotary tablet press for R&D at its new lab in Germany.

Schott and Credence MedSystems have formed a strategic collaboration to make syringe injections safer.

Enterprise Therapeutics has announced that its novel TMEM16A potentiator portfolio has been fully acquired by Roche

Independent research performed at the University of St. Andrews in the UK has reportedly demonstrated the effectiveness of Alfacyte in-vitro against SARS-CoV-2.

A complete listing of event dates for CPhI and Pharmapack Europe 2021 has been released.

In addition to increasing production, Thermo Fisher will create 1000 jobs across its global manufacturing sites to further automation capabilities and optimize warehouse and sterilization capacity.

Following a recent expansion at its Cambridge, MA, facility, the company now houses a new suite of cellular analysis platforms that enhance its exploratory capabilities into oncology, neuroscience, and rare diseases.

The SBV515 Dye from Bio-Rad improves brightness to enhance its use in flow cytometry.

Using the app, biopharmaceutical developers can break through the data wrangling and programming challenges associated with the analysis of large-scale, single-cell datasets.

The system is designed for users seeking to make side-by-side comparisons between cell cultures, run long-term experiments, and monitor cells while working remotely.

The new personal capillary electrophoresis system, Spectrum Compact CE, performs Sanger sequencing and fragment analysis.

The company’s new CytoML Experiment Suite fully automates each stage of the flow cytometry data lifecycle, allowing for clearer data visualization and analysis.

Eudratec Fasteric is an oral drug delivery technology that offers enteric protection after rapid, homogeneous release for targeting the upper small intestine.